Chemours Company (The) — Earnings Quality Grade F
CC · Basic Materials
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 35 days, change -4 days YoY
AR growth -9.2% vs revenue growth 0.4%
Revenue 0.4%, CFFO 141.7%. Cash follows revenue
Expense Quality
Inventory 7.2% vs COGS 5.7%. Normal
CapEx growth -40.8% vs revenue 0.4%. Normal
SG&A/Gross Profit = 88.6%, exceeds 70%
Gross margin 15.5%, change -4.2pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
FCF $0.1B, FCF/NI = -0.13
Accruals ratio = -8.8%. Low accruals
Cash $0.7B covers only 15% of debt $4.4B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 19% of equity. Manageable
Debt/EBITDA = 13.2x (>4x). Interest coverage = -0.1x (<2x). Financial stress
Other assets -7.2% vs revenue 0.4%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -2% YoY. Normal
Manipulation Score
M-Score = -2.90 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor CC continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25